drugset / Trial / NCT03017950

Pharmacokinetic Drug-drug Interaction of CKD-330 and D086

NCT03017950

Phase 1 Completed 83 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of the study is examining and comparing the pharmacokinetic drug interaction and safety of both single administration and combination administration of CKD-330 and D086 to healthy male subjects

Timeline

Start
2016-12
Primary completion
2017-03
Completion
2017-05

Drugs

EvaluationDrugModalityDoseRoute
Subject CKD-330 Unknown
Subject D086 Unknown